Distribution of comorbidities in the PsA and non-PsA SpA groups. Values are n (%) unless otherwise specified.
| Variables | PsA | Non-PsA SpA | p |
|---|---|---|---|
| No. patients with comorbidities | 164/262 (62.59) | 114/256 (44.53) | < 0.001* |
| Males with comorbidities | 97/164 (59.14) | 72/114 (63.15) | 0.50 |
| Multiple comorbidities | 78/262 (29.77) | 42/256 (16.40) | < 0.001* |
| At least 1 CV comorbidity | 86/262 (32.82) | 50/256 (19.53) | < 0.001* |
| More than 1 CV comorbidity | 25/262 (9.54) | 12/256 (4.68) | 0.03* |
| At least 1 metabolic comorbidity | 65/262 (24.80) | 28/256 (10.93) | < 0.001* |
| More than 1 metabolic comorbidity | 21/262 (8.01) | 13/256 (5.07) | 0.17 |
| Total no. comorbidities | 298 | 175 |
↵* Statistically significant. PsA: psoriatic arthritis; non-PsA SpA: non-psoriatic spondyloarthritis; CV: cardiovascular.